HomeComparePZT vs KMB

PZT vs KMB: Dividend Comparison 2026

PZT yields 3.58% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $20.7K in total portfolio value
10 years
PZT
PZT
● Live price
3.58%
Share price
$22.07
Annual div
$0.79
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.2K
Annual income
$450.75
Full PZT calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — PZT vs KMB

📍 KMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPZTKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PZT + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PZT pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PZT
Annual income on $10K today (after 15% tax)
$304.35/yr
After 10yr DRIP, annual income (after tax)
$383.14/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, KMB beats the other by $4,046.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PZT + KMB for your $10,000?

PZT: 50%KMB: 50%
100% KMB50/50100% PZT
Portfolio after 10yr
$35.5K
Annual income
$2,831.03/yr
Blended yield
7.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

PZT
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PZT buys
0
KMB buys
0
No recent congressional trades found for PZT or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPZTKMB
Forward yield3.58%5.25%
Annual dividend / share$0.79$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$25.2K$45.9K
Annual income after 10y$450.75$5,211.33
Total dividends collected$4.1K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PZT vs KMB ($10,000, DRIP)

YearPZT PortfolioPZT Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$11,058$358.06$11,314$613.68$256.00KMB
2$12,202$370.04$12,865$759.19$663.00KMB
3$13,438$381.61$14,709$943.96$1.3KKMB
4$14,771$392.76$16,919$1,180.17$2.1KKMB
5$16,209$403.49$19,588$1,484.33$3.4KKMB
6$17,757$413.79$22,838$1,879.06$5.1KKMB
7$19,424$423.67$26,832$2,395.60$7.4KKMB
8$21,217$433.11$31,788$3,077.63$10.6KKMB
9$23,144$442.14$38,000$3,986.82$14.9KKMB
10$25,215$450.75$45,872$5,211.33$20.7KKMB

PZT vs KMB: Complete Analysis 2026

PZTStock

The Invesco New York AMT-Free Municipal Bond ETF (Fund) is based on The ICE BofAML New York Long-Term Core Plus Municipal Securities Index (Index). The Fund generally will invest at least 80% of its total assets in municipal securities that comprise the Index and that also are exempt from the federal alternative minimum tax. The Index is composed of US dollar-denominated, investment grade, tax-exempt debt publicly issued by New York or any US territory, or their political subdivisions, in the US domestic market with a term of at least 15 years remaining to final maturity. The Index is adjusted monthly and its constituents are capitalization-weighted based on their current amount outstanding. The Fund does not purchase all of the securities in the Index; instead, the Fund utilizes a "sampling" methodology to seek to achieve its investment objective. The Fund and the Index are rebalanced and reconstituted monthly.

Full PZT Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this PZT vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PZT vs SCHDPZT vs JEPIPZT vs OPZT vs KOPZT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.